TFBS Bioscience (ROCO:6939) Notes Receivable: NT$0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6939 TFBS Bioscience Inc ROCO:6939
49 GF Score
Price NT$20.50
GF Value NT$32.08
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is TFBS Bioscience Notes Receivable?

TFBS Bioscience ROCO:6939 +1.49% 49 Notes Receivable is NT$0.0 Mil as of Dec. 2025. GuruFocus rates ROCO:6939 with a GF Score™ of 49/100 and a GF Value™ of NT$32.08 (Possible Value Trap). The stock has 6 warning signs investors should review.

TFBS Bioscience's Notes Receivable for the quarter that ended in Dec. 2025 was NT$0.0 Mil.

TFBS Bioscience Notes Receivable Related Terms

TFBS Bioscience Notes Receivable Historical Data

* Premium members only.

The historical data trend for TFBS Bioscience's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TFBS Bioscience Notes Receivable Chart

TFBS Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

TFBS Bioscience Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6939
49GF Score
TFBS Bioscience Inc ROCO:6939
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TFBS Bioscience Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of NT$0.0 Mil mean?
TFBS Bioscience (ROCO:6939) has a Notes Receivable of NT$0.0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on TFBS Bioscience and its competitors.
Is TFBS Bioscience's Notes Receivable too high?
TFBS Bioscience's current Notes Receivable is NT$0.0 Mil. Overall, TFBS Bioscience has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TFBS Bioscience's Notes Receivable compare to TMO and DHR?
TFBS Bioscience's Notes Receivable of NT$0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Diagnostics & Research company?
A good Notes Receivable depends on the Medical Diagnostics & Research industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on TFBS Bioscience and its competitors. TFBS Bioscience's current Notes Receivable is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TFBS Bioscience stock overvalued right now?
Based on GuruFocus' analysis, TFBS Bioscience (ROCO:6939) is currently considered Possible Value Trap. The stock's GF Value™ is NT$32.08, compared to a current price of NT$20.50 — trading 36.1% below its estimated fair value. The current Notes Receivable is NT$0.0 Mil. TFBS Bioscience's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For TFBS Bioscience (ROCO:6939), the current Notes Receivable is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TFBS Bioscience (ROCO:6939) Overvalued in 2026?

Based on GuruFocus' analysis, TFBS Bioscience stock appears to be undervalued. The current stock price of NT$20.50 is trading 36.1% below its estimated GF Value™ of NT$32.08. GuruFocus considers TFBS Bioscience to be Possible Value Trap.

Key valuation signals for ROCO:6939:

  • Notes Receivable: NT$0.0 Mil
  • GF Value™: NT$32.08 vs. price of NT$20.50 (36.1% below fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the ROCO:6939 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TFBS Bioscience Business Description

Address No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.
49GF Score

Get the complete analysis for ROCO:6939

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$20.50
Price
NT$32.08
GF Value